Marijuana (AP File Photo)
A state panel appointed to review Michigan's medical marijuana law gave preliminary approval on Tuesday to a citizen petition seeking to add post-traumatic stress disorder to the list of debilitating conditions that can qualify a patient for participation in the program.
The Michigan Marihuana Act Review Panel, in a 7-2 vote, recommended adding PTSD to the list. The preliminary vote will be followed by a public hearing, which must be scheduled within 60 days under state rules, before the panel reconvenes to make a formal recommendation.
The head of the Michigan Department of Licensing and Regulatory Affairs, the state agency responsible for appointing the panel and administering the medical marijuana program, will have final say on whether to add PTSD to the list of debilitating conditions.
LARA disbanded a previous iteration of the panel in April after acknowledging failure to appoint members in a manner consistent with administrative rules. The original panel had recommended adding PTSD, and the new-look group, whose members were appointed in June, followed suit in Tuesday's preliminary vote.
"In my opinion, marijuana is one of the best medications for people with PTSD," said appointee David Crocker, a medical doctor from Kalamazoo who serves as president of Michigan Holistic Health. "…We have a lot of veterans with PTSD in our clinics. Many of them will tell you they think marijuana saved their lives, and many of their families will tell you the same thing."
Jeanne Lewandowski of Detroit, a panel member who works as director of palliative medicine at St. John Hospital and Medical Center, spoke out against the petition and was one of two appointees to vote against it. She argued that marijuana could impair the ability of military veterans to reintegrate into society and said she was concerned about social isolation.
In a series of separate votes, the panel rejected petitions seeking to add insomnia, asthma and autism to the list of debilitating conditions under the law. The insomnia vote was preliminary, meaning it will also be subject to a public hearing followed by another vote.
The asthma and autism votes, however, were considered final because the previous iteration of the panel had already considered the petitions and LARA had organized public hearings, frustrating some members who felt the agency was employing a double standard.
"I didn't feel it was appropriate," said David Brogren of Bloomfield Hills, a non-physician panelist who serves as president of Cannabis Patients United. "They disbanded the original panel because it was put together in error. I don't believe the errors were malicious or anything like that -- it wasn't a conspiracy, they just made a mistake -- but I think what they should do was go back to square one on all (the petitions). That would be the most fair thing."
During a public comment section of Tuesday's panel meeting, several marijuana advocates criticized the state for its handling of the review panel, which was envisioned in the 2008 law, mandated by administrative rules established in 2009, but did not meet for the first time until 2012.
A number of advocates questioned whether LARA had again violated the administrative rules by appointing only six members to the panel who also serve on the state's Advisory Committee on Symptom Management. Seven are required.
But Carole Engle, director of LARA's bureau of health care services, expressed confidence that the panel was properly constituted and convened, noting that Michigan Gov. Rick Snyder is expected to appoint another member to the committee who would then serve on the panel moving forward.
"We are convinced that we are not wasting our time," Engle said in response to a question from a panel member. "…We're still missing one member from the advisory committee, but we do have a quorum of appropriately appointed members here today, and that should not impede the panel's ability to make decisions at all."
Read More
Grow Cannabis Indoors
Read More
No comments:
Post a Comment